Jiuzhou Pharma

Jiuzhou Pharma is a leading Chinese CDMO specializing in small molecules and peptides. It has evolved from an API manufacturer into a global provider of contract development and manufacturing services for innovative drugs. The company supports pharmaceutical partners from preclinical development through clinical trials to commercialization. Its own product portfolio includes globally competitive APIs such as carbamazepine and ketoprofen. The company has received regulatory approvals in multiple countries including the US and Australia and maintains partnerships with major pharma companies like Novartis and Roche[2][5][6]. No proprietary clinical trial results are reported; the focus is on enabling client programs.